Board of Directors

The Board of Directors oversees the day-to-day running of our association and the Chairman of the Board is the highest representative of Asebio. The assembly held in December 2019 chose the candidacy with Ana Polanco (Merck) as chairwoman and Belén Barreiro (Ingenasa), Elena Rivas (A4Cell) y Javier Terriente (Zeclinics) as the three vice presidents. They will hold these offices until late 2021.

 

Imagen Ana Polanco - Presidenta de AseBio III

 

Ana Polanco - Presidenta de AseBio

Chairwoman
Ana Polanco

Director of Market Access and Corporate Affairs at Merck since 2015. She is also a member of FEI (Forum of Innovative Companies), of the Board of Directors of the Digital Health Association and Dr. of the Executive Committee of CLOSINGAP.

Belén Barreiro
1st Vice President
Belén Barreiro

General Director at Ingenasa, a company specializing in biotechnology for the veterinary sector, which she joined in 1994 as marketing director.

Elena Rivas
2sd Vice President
Elena Rivas

CEO at Arrays for Cell Nanodevices, SL

javier terriente

vicepresidente 3º

3rd Vice President
Javier Terriente

CSO at Zeclinics

Dámaso Molero
Member of the Board
Dámaso Molero

General Director at 3P Biopharmaceuticals since 2007, Dámaso Molero has a long experience in pharmaceutical production, with more than 10 years as a plant manager in Shionogi

Antonio Bañares
Member of the Board
Antonio Bañares

Director of Market Access and Governance at AbbVie since 2013. He had been previously Director of Health Management and Institutional Relations at Abbott Laboratories and General Director of the company's foundation.

Carles Domenech
Member of the Board
Carles Domenech

CEO and Vice President of Business Development and Licensing at Ability Pharma since 2009. At the same time, he has been a consultant for biotech projects of the investment company Kieretsu Forum Spain.

rocío arroyo

vocal

Member of the Board
Rocío Arroyo

CEO at Advanced Maker Discovery

Santiago de Torres
Member of the Board
Santiago de Torres

Executive Chairman of the Board at Atrys Health. Torres, a physician specializing in Clinical Pharmacology, is also part of the board of various organizations with social purposes.

Soraya Gamonal
Member of the Board
Soraya Gamonal

Head of Innovation for Spain, Portugal and Latin America at Ayming, a company she joined in 2007 as a senior R&D consultant.

Richard Borreani
Member of the Board
Richard Borreani

Director of Agricultural Policies and Institutional Relations at Bayer Crop Science Iberia, the agro division of the multinational, which is the third largest company in the world in products for agriculture.

Enrique Castellón
Member of the Board
Enrique Castellón

Co-founder and president since 2001 of the investment company Cross Road Biotech, Castellón was Secretary of State for Health and Consumer Affairs (1996-2000), a position from which he promoted multiple projects of great relevance to the sector.

Sin imagen
Vocal
Nora Alonso

CEO at Iden Biotechnology

Sin imagen
Member of the Board
Enrique Samper
Sin imagen
Member of the Board
Belén Sopesén

Director Corporate Affairs

Sin imagen
Member of the Board
Christian Sánchez
Sin imagen
Vocal
Antonio López

CEO at Science & Innovation Link Office (SILO)

Sin imagen
Vocal
Gurutz Linazasoro

CEO at Vivebiotech

Andrés Ballesteros
Member of the Board
Andrés Ballesteros

Founding partner and CEO at Vivia Biotech, a company specializing in drug screening, which he joined after 10 years working as a lawyer in the United States.